{"id":"ampicillin-for-injection","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"1-3","effect":"Rash"},{"rate":"1-3","effect":"Nausea"},{"rate":"0.1-1","effect":"Allergic reaction / Anaphylaxis"},{"rate":"0.1-1","effect":"Pseudomembranous colitis"}]},"_chembl":{"chemblId":"CHEMBL1200758","moleculeType":"Small molecule","molecularWeight":"371.39"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ampicillin works by disrupting the formation of the bacterial cell wall, which is essential for bacterial survival and structural integrity. By inhibiting peptidoglycan synthesis, the drug causes cell wall weakening and bacterial lysis. This bactericidal mechanism is effective against a broad spectrum of gram-positive and some gram-negative bacteria.","oneSentence":"Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and preventing peptidoglycan cross-linking.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:13.943Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections caused by susceptible organisms (respiratory tract infections, urinary tract infections, meningitis, endocarditis, septicemia)"},{"name":"Prophylaxis of bacterial endocarditis"}]},"trialDetails":[{"nctId":"NCT04948463","phase":"PHASE4","title":"Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2021-11-15","conditions":"Febrile Neutropenia","enrollment":55},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT04514653","phase":"PHASE2","title":"RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2020-08-25","conditions":"Neovascular Age-Related Macular Degeneration (nAMD)","enrollment":146},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT05355350","phase":"PHASE4","title":"PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections","status":"WITHDRAWN","sponsor":"Rambam Health Care Campus","startDate":"2022-07-01","conditions":"Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia","enrollment":""},{"nctId":"NCT02570347","phase":"PHASE4","title":"Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite","status":"TERMINATED","sponsor":"Jawaharlal Institute of Postgraduate Medical Education & Research","startDate":"2016-05-03","conditions":"Snake Bites","enrollment":66},{"nctId":"NCT03891433","phase":"PHASE4","title":"Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae","status":"SUSPENDED","sponsor":"Universidad del Norte","startDate":"2019-04-01","conditions":"Urinary Tract Infections, Enterobacteriaceae Infections, Infection Due to ESBL Bacteria","enrollment":198},{"nctId":"NCT06123832","phase":"","title":"Study of the Clinical Benefits of Different Formulations of Amphotericin B","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-09-01","conditions":"Efficacy, Safety","enrollment":184},{"nctId":"NCT05804123","phase":"NA","title":"LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2021-10-28","conditions":"Upper Respiratory Tract Infections","enrollment":175},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT06076200","phase":"","title":"Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations","status":"RECRUITING","sponsor":"Shandong University","startDate":"2023-09-30","conditions":"Early-Onset Neonatal Sepsis","enrollment":50},{"nctId":"NCT05981079","phase":"PHASE4","title":"Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2023-07-31","conditions":"Late-Onset Neonatal Sepsis","enrollment":332},{"nctId":"NCT05943223","phase":"PHASE2","title":"Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)","status":"UNKNOWN","sponsor":"McMaster Children's Hospital","startDate":"2024-01","conditions":"Appendicitis Perforated","enrollment":16},{"nctId":"NCT05916742","phase":"NA","title":"Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession","status":"UNKNOWN","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2022-04-15","conditions":"Gingival Recession","enrollment":75},{"nctId":"NCT05393505","phase":"PHASE4","title":"Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-10-24","conditions":"Neutropenic Fever","enrollment":344},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT04629378","phase":"PHASE2","title":"Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB","status":"COMPLETED","sponsor":"TASK Applied Science","startDate":"2020-08-17","conditions":"Tuberculosis","enrollment":22},{"nctId":"NCT03369093","phase":"NA","title":"RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2018-01-01","conditions":"Treatment Failure, Lethargy, Altered Mental Status","enrollment":308},{"nctId":"NCT01760109","phase":"PHASE4","title":"Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2011-07","conditions":"Respiratory Tract Infections, Urinary Tract Infections","enrollment":2000},{"nctId":"NCT03757052","phase":"NA","title":"Amoxicillin Challenge for Penicillin Allergy Diagnosis","status":"UNKNOWN","sponsor":"CHU de Quebec-Universite Laval","startDate":"2018-11-20","conditions":"Penicillin Allergy","enrollment":1000},{"nctId":"NCT03248973","phase":"","title":"Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester","status":"COMPLETED","sponsor":"Far Eastern Memorial Hospital","startDate":"2017-04-03","conditions":"Listeria Monocytogenes","enrollment":1},{"nctId":"NCT01312792","phase":"NA","title":"Operational Research Management for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2010-08","conditions":"Pneumonia","enrollment":300},{"nctId":"NCT01192789","phase":"NA","title":"Community Case Management of the Severe Pneumonia With Oral Amoxicillin in Children 2-59 Months of Age","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2008-02","conditions":"Severe Pneumonia","enrollment":4070},{"nctId":"NCT01793688","phase":"","title":"Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-03-12","conditions":"Pneumonia, Lung Abscess, Peritonitis","enrollment":982},{"nctId":"NCT02837614","phase":"EARLY_PHASE1","title":"Evaluation of Preoperative Submucosal Dexamethasone in Third Molar Surgery","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-10","conditions":"Impacted Third Molar Tooth","enrollment":60},{"nctId":"NCT00801099","phase":"NA","title":"Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections","status":"COMPLETED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2004-12","conditions":"Surgical Site Infection","enrollment":276},{"nctId":"NCT01027429","phase":"PHASE3","title":"Simplified Antibiotic Therapy for Sepsis in Young Infants","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2009-12","conditions":"Neonatal Sepsis, Sepsis, Infection","enrollment":2543},{"nctId":"NCT00844337","phase":"NA","title":"Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2009-03","conditions":"Sepsis","enrollment":2490},{"nctId":"NCT01310361","phase":"PHASE1","title":"Once-daily Therapy for Streptococcal Pharyngitis","status":"COMPLETED","sponsor":"Azad University of Medical Sciences","startDate":"2004-01","conditions":"Streptococcal Sore Throat","enrollment":""},{"nctId":"NCT00924742","phase":"NA","title":"A Single-Dose Pharmacokinetics Study of Tapimycin Injection","status":"COMPLETED","sponsor":"Tri-Service General Hospital","startDate":"2009-03","conditions":"Healthy","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ampicillin for Injection","genericName":"Ampicillin for Injection","companyName":"Medical College of Wisconsin","companyId":"medical-college-of-wisconsin","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and preventing peptidoglycan cross-linking. Used for Bacterial infections caused by susceptible organisms (respiratory tract infections, urinary tract infections, meningitis, endocarditis, septicemia), Prophylaxis of bacterial endocarditis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}